ArticleBlood advances2023

Final analysis of carfilzomib, dexamethasone, and daratumumab vs carfilzomib and dexamethasone in the CANDOR study.

Saad Z Usmani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.